Comparison of Outcomes and Access to Care for Heart Failure Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

5,452

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

December 1, 2021

Study Completion Date

August 31, 2022

Conditions
Heart Failure
Interventions
OTHER

Risk stratification and transitional care intervention

"Intervention consists of 2 components:~1. Risk stratification: Determination of risk using the EHMRG 7-day and 30-day risk scores (EHMRG30-ST), where decision to admit, observe, or discharge the patient will be guided by the result of the risk scores~2. Transitional care: Follow-up care in the RAPID-HF transitional care clinic begins at 48-72 hours after emergency department or hospital discharge. Care provided by cardiologist + nurse for up to 30 days after emergency department or hospital discharge."

Trial Locations (1)

M5G2C4

Toronto Genera Hospital, Toronto

All Listed Sponsors
lead

Institute for Clinical Evaluative Sciences

OTHER

NCT02674438 - Comparison of Outcomes and Access to Care for Heart Failure Trial | Biotech Hunter | Biotech Hunter